Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Merck KGaA Teams Up With Mersana On STING Agonist ADCs

Dec 30 2022

• By Joseph Haas and Ayisha Sharma

Deal Watch 2021 — • Source: Shutterstock

Related Content

Lupin Turns Up Heat With Bausch Brands Acquisition, Perforomist Generic Launch

Dec 01 2022

Alvotech Targets MENA In Multi-Biosimilar Commercialization Deal

Dec 12 2022

Biocon And Zentiva Sign Liraglutide Deal For 30 European Countries

Dec 02 2022

Lilly To Try ProQR’s RNA-Editing Technology In Liver, Neurology Indications

Sep 09 2021

BioNTech Bolsters Cancer Immunotherapy Ambitions In Pact With Cash-Poor Ryvu

Nov 30 2022

VistaGen Staggered By Latest Clinical Setback, This Time In Social Anxiety

Jul 22 2022

Pfizer Returns To Roivant As Development Partner For A Second Time

Dec 01 2022

LegoChem’s $1.2bn ADC Platform Deal With Amgen Signals Continued Big Pharma Interest

Dec 23 2022

Gilead's Kite To Buy Tmunity, Enhancing CAR-T Pipeline And Manufacturing

Dec 20 2022

Sanofi Gains New Innate Program In Expanded Collaboration

Dec 19 2022

Finance Watch: Public Biopharma Firms Take Advantage Of Relative Upswing

Dec 19 2022

Sosei Heptares Adds Lilly To Big Pharma Client List

Dec 16 2022

Takeda Aims At BMS’s Sotyktu In $4bn Deal For Nimbus’s TYK2 Inhibitor

Dec 13 2022

Wave Banks $170m Upfront In GSK Oligonucleotide Deal, Analysts Back Shift To Partnership Model

Dec 14 2022

Nordic Nanovector In Limbo As Merger Collapses

Dec 12 2022

Amgen To Enhance Rare Disease Franchise With $27.8bn Horizon Takeover

Dec 12 2022

Vertex Adds To Myotonic Dystrophy Effort With Entrada Collaboration

Dec 08 2022

Deal With Arcellx Gives Gilead New Beachhead In Multiple Myeloma

Dec 09 2022

MorphoSys Teams Up Again With Novartis For Preclinical Cancer Program

Dec 07 2022

Horizon Megadeal: J&J Out, Experts Say Sanofi Could Have Edge On Amgen

Dec 06 2022

TherapeuticsMD Finds New Exit With Mayne Pharma Licensing Pact

Dec 05 2022

Midatech Bets on Bioasis Merger For Survival

Dec 15 2022

Related Companies

Eli Lilly and Company

ProQR Therapeutics N.V.

Harrow, Inc.

Novartis AG

Erasca, Inc.

University of Texas MD Anderson Cancer Center

VistaGen Therapeutics, Inc.

Pherin Pharmaceuticals, Inc.

Ordaos Bio

Yatiri Bio

Vallon Pharmaceuticals Inc.

GRI Bio, Inc.

Cosmo Pharmaceuticals N.V.

Ethris GmbH

DIOSynVax

AbCellera Biologics Inc.

Praxis Precision Medicines, Inc.

Tonix Pharmaceuticals Holding Corp.

Curia Global, Inc.

Tris Pharma, Inc.

Essential Pharma

Janssen Pharmaceutica NV

Caris Life Sciences

Hummingbird Bioscience

HotSpot Therapeutics, Inc.

Pfizer Inc.

Clear Creek Bio, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.